That said, we believe LNCR may be unmolested by government cuts for at least 2011-2012, perhaps longer.

FORBES: Volume Surges on LNCR Following Citigroup Report

Shares of Lincare Holdings ( LNCR) are experiencing unusual volume today.

FORBES: Volume Surges on LNCR Following Citigroup Report

We continue to believe that LNCR is a near and long-term winner from the consolidation of the industry that is underway, and we still believe the shares are under-valued.

FORBES: Volume Surges on LNCR Following Citigroup Report

Also in health care, Moroney cites consistent growth and solid finances as factors that should boost Biomet (nasdaq: BMET - news - people ) and Lincare Holdings (nasdaq: LNCR - news - people ).

FORBES: Hunting For Growth

Among the largest underlying components of FXH, in trading today Lincare Holdings Inc. ( NASD: LNCR) is trading flat, Watson Pharmaceuticals, Inc. ( NYSE: WPI) is up about 0.3%, and Forest Laboratories, Inc. ( NYSE: FRX) is higher by about 0.7%.

FORBES: FXH, LNCR, WPI, FRX: ETF Outflow Alert